Global X Video Games & Esports ETF HERO
28.35 USD +0.25 (+0.89%)
Regular-session close
28.35 0.00 0.00%
After hours · Nov 18, 4:00 PM ET
28.26 Day range 28.51
23.59 52-week range 31.41
- YTD
- -4.74%
- 1 year
- -8.67%
News
247wallst.com Take-Two Is Surging on GTA VI's Launch, and Your Index Fund Might Be Along for the Ride Without You Knowing It GTA VI just lit up Take-Two's stock, but the bigger story sits inside your retirement account. Three kinds of funds hold the stock, and they feel this launch very differently, so check which ones you…
seekingalpha.com Aardvark Therapeutics, Inc. (AARD) Discusses Efficacy and Safety Data From Terminated HERO Phase III and Open-Label Extension Trials Transcript Aardvark Therapeutics, Inc. (AARD) Discusses Efficacy and Safety Data From Terminated HERO Phase III and Open-Label Extension Trials Transcript
globenewswire.com Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials SAN DIEGO, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark or the Company) (Nasdaq: AARD), a clinical-stage biopharmaceutical company developing novel, small-molecule…
defenseworld.net 106,976 Global X Video Games & Esports ETF $HERO Shares Bought by Envestnet Asset Management Inc. Envestnet Asset Management Inc. raised its holdings in Global X Video Games and Esports ETF (NASDAQ: HERO) by 306.2% during the second quarter, according to its most recent filing with the Securities…
gurufocus.com AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 AARD DEADLINE NOTICE: Faruqi and Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026PR NewswireNEW YORK,
gurufocus.com AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class ActionPR NewswireSAN FRANCISCO,
gurufocus.com Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli
gurufocus.com Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately
gurufocus.com Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 Deadline Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 De
247wallst.com 4 Battle-Tested Consumer Staples Stocks That Keep Raising Their Dividends Some dividend stocks fold the moment a recession hits, but four consumer staples names kept raising their payouts straight through a housing collapse and a global lockdown without missing a beat.
gurufocus.com Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli
gurufocus.com Deadline Approaching: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith Law Offices of Howard G. Smith reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of invest
gurufocus.com Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit [url="]Glancy Prongay Wolke and Rotter LLP[/url] reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action f
gurufocus.com Deadline Soon: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit [url="]The Law Offices of Frank R. Cruz[/url] reminds investors of the upcoming October 13, 2026 deadline to participate as a lead plaintiff in the securities f
gurufocus.com AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 [url="]Faruqi and Faruqi, LLP[/url], a leading national securities law firm, is investigating potential claims against Aardvark Therapeutics, Inc. (âAardvarkâ
finbold.com Here are this week's top-performing ETFs; Time to buy? Exchange-traded funds (ETFs) tied to enterprise software, cloud computing, video gaming, and innovation stocks delivered some of the strongest gains in the market over the past week.
gurufocus.com Duke Energy supports South Carolina first responders with $500,000 in grants for emergency preparedness Duke Energy supports South Carolina first responders with $500,000 in grants for emergency preparedness PR Newswire
prnewswire.com Duke Energy supports South Carolina first responders with $500,000 in grants for emergency preparedness Funding goes to 34 nonprofits and government agencies across the Palmetto State Since 2022, Duke Energy's HERO Grant Program has funded 133 grants with $2.5 million, delivering critical support to…
globenewswire.com Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark or the Company) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel,…
247wallst.com Forget Generic Gaming Plays: 3 ETFs Reveal the Real Digital Entertainment Divide Digital entertainment has grown into one of the largest discretionary categories for consumers, and it continues to draw more time and attention every year.
